|Back to Search Results|
Gary SimonRoss Professorship of Clinical Research
Walter G. Ross
Professor of Medicine
Professor of Biochemistry and Molecular Medicine (Secondary)
Office Phone: 202-741-2234
- BS, University of Maryland, College Park, 1968
- MS, University of Wisconsin, 1970
- PhD, University of Wisconsin, 1972
- MD, University of Maryland School of Medicine, 1975
Dr. Simon received his B.S. degree from the University of Maryland, a Ph.D. in physical chemistry from the University of Wisconsin and an M.D. degree from the University of Maryland where he was elected to AOA. He completed residency training at the University of Maryland Hospital and a fellowship in infectious diseases at Tufts-New England Medical Center. He joined the faculty at GW in 1980. He has been the director of the division since 1993. Dr. Simon serves as Director of Research for the GW Medical Faculty Associates and the clinical departments of the GW School of Medicine and Health Sciences. He is also co-director of the NIH-funded DC-Center for AIDS Research.
Dr. Simon’s awards include the Laureate award from the American College of Physicians and the GW School of Medicine and Health Sciences Distinguished Researcher Award. He was elected to mastership in the American College of Physicians in 2008.
His areas of interest include HIV infection, HIV-related opportunistic infections and HIV comorbidities. Other areas of interest include bacteremia, septic shock and surgical infections. In addition, during the past three decades the infectious disease group at GW has been involved in clinical trials of virtually every drug that has been used to treat HIV infection. Current studies are directed towards examining HIV-mediated inflammation.
- Active member in the local ACP chapter
- Infectious Diseases
View publications by this faculty member from January 1, 2013 - present
Nixon DF, Simon GL, Raposo RAF. Identification of HIV remission ready patients through immunogenomics. J Acq Imm Def Syn 68:e9-10, 2015.
Sahu G, Farley K, El-Hage, N, Aiamkitsumrit B, Fassnacht R, Kashanchi F, Ochem A, Simon, GL, Karn J, Hauser KF, Tyagi M. Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-?B and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR. Virology. 2015 September;483;185–202. doi:10.1016/j.virol.2015.03.036.
Roberts AD, Simon, GL. Diabetic Foot Infections. In: Essentials of Vascular Surgery for the General Surgeon. R. Neville, ed. Springer Press, 2014.
Toma I, Siegel MO, Keiser J, Yakovleva A, Kim A, Davenport L, Devaney J, Hoffman EP, Alsubail R, Crandall KA, Castro-Nallar E, Perez-Losada M, Hilton S, Chawla LS, McCaffrey TA, Simon GL. Single-Molecule Long Read 16S Sequencing to Characterize the Lung Microbiome from Mechanically Ventilated Patients with Suspected Pneumonia. J Clin Microbiol. 52:3913-21;2014.
Nayak S, Simon GL. Myocarditis after trimethoprim/ sulfamethoxazole treatment for ehrlichiosis. Emerg Infect Dis. 19:1975-7, 2013. http://dx.doi.org/10.3201/eid1912.121459
Siegel M, Simon GL. Is Human Immunodeficiency Virus Infection a Risk Factor for Strongyloides stercoralis Hyperinfection and Dissemination? Public Library of Science-Neglected Tropical Diseases. 31 Jul 2012 10.1371/journal.pntd.0001581
Jordan JA, Ibe CO, Moore MS, Host C, Simon GL. Evaluations of a Manual DNA Extraction Protocol and an Isothermal Amplification Assay for Detecting HIV-1 DNA from Dried Blood Spots for Use in Resource-limited Settings. J Clin Virol. 54;11-4, 2012.
Roberts AD, Simon, GL. Diabetic foot infections; the role of microbiology and antibiotic treatment. Sem. Vasc. Surg. 25:75-81; 2012.
Additional publications published before January 1, 2013 may be available within Himmelfarb Library's database.
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has reported a financial interest with the healthcare related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.
- Gilead Sciences
- Jazz Pharmaceuticals
- Pfizer Pharmaceuticals